Skip to main content
Pediatric Annals, 2013;32(8):528–535
Published Online:https://doi.org/10.3928/0090-4481-20030801-10Cited by:14
First page image

  • 1. The Cystic Fibrosis Mutations Database. http://www.geneLskkkids.cffl.ca/cftr. Accessed July 14. 2003.

    > Google Scholar
  • 2. FarreUPM,KosorokMR,RockMJ,etaLEarly diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001;107:1-13.

    > Google Scholar
  • 3. Wang SS, O'Leary LA, FitzSimmons SC, Khoury MJ. The impact of early cystic fibrosis diagnosis on pulmonary function in children. J Pediatr. 2002;141:804-810.

    > Google Scholar
  • 4. Cono J, Quails N, Khoury M, Harmon W. Newborn Screening for Cystic Fibrosis: A Paradigm for Public Health Genetics Policy DevelopmenL Proceedings of a 1997 Workshop. MMWR. 1997;46[RR-16]:l-24

    > Google Scholar
  • 5. Abman SH, Ogle JW, Butler-Simon N, Rumack CM, Accurso FJ. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr. 1988;113:826-830.

    > Google Scholar
  • 6. Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979;l(8114):472-474.

    > Google Scholar
  • 7. Iovanna JL, Ferec C, Series J, Dagom JC. The pancreatitis-associated protein (PAP). A new candidate for neonatal screening of cystic fibrosis. CRAcadScini. 1994;317:561-564.

    > Google Scholar
  • 8. Gregg RG, Simantel A, Farrell PM, et al. Newbom screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics. 1997;99:819-824.

    > Google Scholar
  • 9. Farrell PM, Kosorok MR, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med 1997;337:963-969.

    > Google Scholar
  • 10. Gregg RG, Wilfond BS, Farrell PM, et al. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocois. Am J Hum Genet. 1993;52:616-626.

    > Google Scholar
  • 11. Massie RJ, Olsen M, Glazner J, Robertson CF, Francis I. Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). MedJAust. 2000;172:584-587.

    > Google Scholar
  • 12. Grody WW, Cutting GR, Klinger KW, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med. 2001;3:149-154.

    > Google Scholar
  • 13. Scotet V, De Braekeleer M, Audrezet MP, et al. Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis. Clin Genet. 2001;59:42-47.

    > Google Scholar
  • 14. Padoan R, Bassotti A, Seia M, Corbetta C. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations. Eur J Pediatr. 2002;161:212-215.

    > Google Scholar
  • 15. Castellani C, Tamanini A, Mastella G. Protracted neonatal hypertrypsinogenaernia, normal sweat chloride, and cystic fibrosis. Arch DL· Child. 2000;82:481-482.

    > Google Scholar
  • 16. Massie J, Du SD, Forshaw K, Carlin J, Forrest SM. The relationship between neonatal immunoreactive trypsinogen, ??508, and IVS8-5T [letter]. J Med Genet. 2000;37:629632.

    > Google Scholar
  • 17. Castellani C, Bonizzato A Mastella G. CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test J Med Genet. 1997;34:297-301.

    > Google Scholar
  • 18. West SE, Zeng L, Lee BL, et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA. 2002;287:2958-2967.

    > Google Scholar
  • 19. Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr PuImonoL 1998;26:81-88.

    > Google Scholar
  • 20. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32:277-287.

    > Google Scholar
  • 21. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. / Pediatr. 2001;138:699-704.

    > Google Scholar
  • 22. Waters DL Wilcken B, Irwing L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed. 1999;80:F1-F7.

    > Google Scholar
  • 23. Chatfield S, Owen G, Ryley HC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after 5 years of screening. Arch Dis Child 1991;66:29-33.

    > Google Scholar
  • 24. Bowling F, Cleghorn G, Chester A et al. Neonatal screening for cystic fibrosis. Arch Dis Child 1988;63:196-198.

    > Google Scholar
  • 25. Assael BM, Castellani C, Ocampo MB, et al. Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years. Am J Epidemiol 2002; 156:397401.

    > Google Scholar
  • 26. Dankert-Roelse JE, te Meerman GJ, Martijn A, Ten Kate LP, Knol K. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J Pediatr. 1989;114:362-367.

    > Google Scholar
  • 27. Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre [see comments!. Thorax. 1995;50:712-718.

    > Google Scholar
  • 28. Merelle ME, Schouten JP, Gerritsen J, DankertRoelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J. 2001;18:306-315.

    > Google Scholar
  • 29. Siret D, Bretaudeau G, Branger B, et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol 2O03;35(5):342-349.

    > Google Scholar
  • 30. Scotet V, De Braekeleer M, Roussey M, et al. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 1 0 years' experience and impact on prenatal diagnosis. Lancet. 2O00;356(9232):789-794.

    > Google Scholar
  • 31. Weaver LT, Green MR, Nicholson K, Mills J, Heeley ME, Kuzemko JA et al Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child 1994;70:84-89.

    > Google Scholar
  • 32. Sokol RJ, Reardon MC, Accurso FJ, et al. Fatsoluble vitamins in infants identified by cystic fibrosis newborn screening. Pediatr Pulmonol SuppL 1991;7:52-55.

    > Google Scholar
  • 33. Feranchak AP, Sontag MK, Wagener JS, et al. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. / Pediatr. 1999;135(5):601-610.

    > Google Scholar
  • 34. Bronstein MN, Sokol RJ, Abman SH, et al. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr. 1992;120:533-540.

    > Google Scholar
  • 35. Abman SH, Ogle JW, Harbeck RJ, et al. Early bactériologie, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr. 1991;119:211-217.

    > Google Scholar
  • 36. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Can; Med 1995; 151:1075-1082.

    > Google Scholar
  • 37. Mohon RT, Wagener JS, Abman SH, Seltzer WK, Accurso FJ. Relationship of genotype to early pulmonary function in infants with cystic fibrosis identified through neonatal screening. J Pediatr. 1993;122:550-555.

    > Google Scholar
  • 38. Farrell PM, Koscik RE. Sweat chloride concentrations in infants homozygous or heterozygous for AF508 cystic fibrosis. Pediatrics. 1996;97:524-528.

    > Google Scholar
  • 39. US Task Force on Newborn Screening. Report of US Task Force on Newborn Screening. Pediatrics. 2000;106:389-422.

    > Google Scholar
  • 40. Ai-Jader LN, Goodchild MC, Ryley HC, Harper PS. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Adv Exp Med BioL 1991 £90:347348.

    > Google Scholar
  • 41. Tluczek A, Mischler EH, Farrell PM, et al. Parents' knowledge of neonatal screening and response to false- positive cystic fibrosis testing. J Dev Behav Pediatr. 1992;13:181-186.

    > Google Scholar
  • 42. Mischler EH, Wilfond BS, Post N, et al. Cystic Fibrosis Newborn Screening; Impact on Reproductive Behavior and Implicatations for Genetic Counseling. Pediatrics. 1998;102:44-51.

    > Google Scholar
  • 43. Helton JL, Harmon RJ, Robinson N, Accurso FJ. Parental attitudes toward newborn screening for cystic fibrosis. Pediatr Pulmonol SuppL 1991;7:23-28.

    > Google Scholar
  • 44. Ai-Jader LN, Goodchild MC, Ryley HC, Harper PS. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet. 1990;38:46O465.

    > Google Scholar
  • 45. Boland C, Thompson NL. Effects of newborn screening of cystic fibrosis on reported maternal behaviour. Arch Dis Child 1990;65:1240-1244.

    > Google Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×